刺
免疫疗法
医学
癌症免疫疗法
干扰素基因刺激剂
癌症治疗
癌症
免疫学
先天免疫系统
免疫系统
癌症研究
内科学
工程类
航空航天工程
作者
Zhuoying Tian,Yue Zeng,Yurong Peng,Junqi Liu,Fang Wu
标识
DOI:10.3389/fimmu.2022.996663
摘要
Activation of the cGAS-STING pathway by cytoplasmic DNA induces the production of Type-1 interferons. Recent advances in research suggest that the cGAS-STING pathway is involved in different parts of the cancer-immunity cycle (CIC) to promote or suppress antitumor immune responses. Combination therapy of STING agonists has made certain progress in preclinical as well as clinical trials, but the selection of combination therapy regimens remains a challenge. In this review, we summarize the role of the cGAS-STING in all aspects of CIC, and focus on the combination immunotherapy strategies of STING agonists and current unsolved challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI